Fingerprint
Dive into the research topics of 'Type I interferon is selectively required by dendritic cells for immune rejection of tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Mark S. Diamond, Michelle Kinder, Hirokazu Matsushita, Mona Mashayekhi, Gavin P. Dunn, Jessica M. Archambault, Hsiaoju Lee, Cora D. Arthur, J. Michael White, Ulrich Kalinke, Kenneth M. Murphy, Robert D. Schreiber
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Division of Immunobiology
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Rheumatic Diseases Research Resource-Based Center
- DBBS - Molecular Cell Biology
- DBBS - Developmental, Regenerative and Stem Cell Biology
- DBBS - Immunology
- DBBS - Cancer Biology
- Brain Tumor Center
Research output: Contribution to journal › Article › peer-review
881
Scopus
citations